Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Pharma & Healthcare
Published Date: 2025-03-19
Pages: 80 Pages
Report ld: 4677041
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Octreotide Market Size(US$)
CAGR 2025-2031
-2.8%
Market Size,2031
USD 2.3
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2.8 million
Market Forecast in 2031(Value)
US$ 2.3 million
CAGR
-2.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
The global Octreotide market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Novartis
- Sun Pharmaceutical
- Chengdu Tiantaishan pharmaceutical
- Sinopharm A-Think Pharmaceuticals
- Sihuan Pharmaceutical Holdings Group
- Shanghai Soho-Yiming Pharmaceuticals
- Yibin Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Octreotide Injection
- Octreotide Powder
- Octreotide Microspheres
Segment by Application
- Treating Severe Diarrhea
- Treating Acromegaly
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Octreotide market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Octreotide Powder in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Treating Acromegaly in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Octreotide Injection dominance in Europe vs. Octreotide Powder demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Octreotide Product Scope
1.2 Octreotide by Type
1.2.1 Global Octreotide Sales by Type (2020 & 2024 & 2031)
1.2.2 Octreotide Injection
1.2.3 Octreotide Powder
1.2.4 Octreotide Microspheres
1.3 Octreotide by Application
1.3.1 Global Octreotide Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Treating Severe Diarrhea
1.3.3 Treating Acromegaly
1.3.4 Others
1.4 Global Octreotide Market Estimates and Forecasts (2020-2031)
1.4.1 Global Octreotide Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Octreotide Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Octreotide Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Octreotide Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Octreotide Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Octreotide Sales Market Share by Region (2020-2025)
2.2.2 Global Octreotide Revenue Market Share by Region (2020-2025)
2.3 Global Octreotide Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Octreotide Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Octreotide Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Octreotide Market Size and Prospective (2020-2031)
2.4.2 Europe Octreotide Market Size and Prospective (2020-2031)
2.4.3 China Octreotide Market Size and Prospective (2020-2031)
2.4.4 Japan Octreotide Market Size and Prospective (2020-2031)
2.4.5 India Octreotide Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Octreotide Historic Market Review by Type (2020-2025)
3.1.1 Global Octreotide Sales by Type (2020-2025)
3.1.2 Global Octreotide Revenue by Type (2020-2025)
3.1.3 Global Octreotide Price by Type (2020-2025)
3.2 Global Octreotide Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Octreotide Sales Forecast by Type (2026-2031)
3.2.2 Global Octreotide Revenue Forecast by Type (2026-2031)
3.2.3 Global Octreotide Price Forecast by Type (2026-2031)
3.3 Different Types Octreotide Representative Players
4 Global Market Size by Application
4.1 Global Octreotide Historic Market Review by Application (2020-2025)
4.1.1 Global Octreotide Sales by Application (2020-2025)
4.1.2 Global Octreotide Revenue by Application (2020-2025)
4.1.3 Global Octreotide Price by Application (2020-2025)
4.2 Global Octreotide Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Octreotide Sales Forecast by Application (2026-2031)
4.2.2 Global Octreotide Revenue Forecast by Application (2026-2031)
4.2.3 Global Octreotide Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Octreotide Application
5 Competition Landscape by Players
5.1 Global Octreotide Sales by Players (2020-2025)
5.2 Global Top Octreotide Players by Revenue (2020-2025)
5.3 Global Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Octreotide as of 2024)
5.4 Global Octreotide Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Octreotide, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Octreotide, Product Type & Application
5.7 Global Key Manufacturers of Octreotide, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Octreotide Sales by Company
6.1.1.1 North America Octreotide Sales by Company (2020-2025)
6.1.1.2 North America Octreotide Revenue by Company (2020-2025)
6.1.2 North America Octreotide Sales Breakdown by Type (2020-2025)
6.1.3 North America Octreotide Sales Breakdown by Application (2020-2025)
6.1.4 North America Octreotide Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Octreotide Sales by Company
6.2.1.1 Europe Octreotide Sales by Company (2020-2025)
6.2.1.2 Europe Octreotide Revenue by Company (2020-2025)
6.2.2 Europe Octreotide Sales Breakdown by Type (2020-2025)
6.2.3 Europe Octreotide Sales Breakdown by Application (2020-2025)
6.2.4 Europe Octreotide Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Octreotide Sales by Company
6.3.1.1 China Octreotide Sales by Company (2020-2025)
6.3.1.2 China Octreotide Revenue by Company (2020-2025)
6.3.2 China Octreotide Sales Breakdown by Type (2020-2025)
6.3.3 China Octreotide Sales Breakdown by Application (2020-2025)
6.3.4 China Octreotide Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Octreotide Sales by Company
6.4.1.1 Japan Octreotide Sales by Company (2020-2025)
6.4.1.2 Japan Octreotide Revenue by Company (2020-2025)
6.4.2 Japan Octreotide Sales Breakdown by Type (2020-2025)
6.4.3 Japan Octreotide Sales Breakdown by Application (2020-2025)
6.4.4 Japan Octreotide Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Octreotide Sales by Company
6.5.1.1 India Octreotide Sales by Company (2020-2025)
6.5.1.2 India Octreotide Revenue by Company (2020-2025)
6.5.2 India Octreotide Sales Breakdown by Type (2020-2025)
6.5.3 India Octreotide Sales Breakdown by Application (2020-2025)
6.5.4 India Octreotide Major Customer
6.5.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Novartis
7.1.1 Novartis Company Information
7.1.2 Novartis Business Overview
7.1.3 Novartis Octreotide Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Novartis Octreotide Products Offered
7.1.5 Novartis Recent Development
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Company Information
7.2.2 Sun Pharmaceutical Business Overview
7.2.3 Sun Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Sun Pharmaceutical Octreotide Products Offered
7.2.5 Sun Pharmaceutical Recent Development
7.3 Chengdu Tiantaishan pharmaceutical
7.3.1 Chengdu Tiantaishan pharmaceutical Company Information
7.3.2 Chengdu Tiantaishan pharmaceutical Business Overview
7.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Products Offered
7.3.5 Chengdu Tiantaishan pharmaceutical Recent Development
7.4 Sinopharm A-Think Pharmaceuticals
7.4.1 Sinopharm A-Think Pharmaceuticals Company Information
7.4.2 Sinopharm A-Think Pharmaceuticals Business Overview
7.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Products Offered
7.4.5 Sinopharm A-Think Pharmaceuticals Recent Development
7.5 Sihuan Pharmaceutical Holdings Group
7.5.1 Sihuan Pharmaceutical Holdings Group Company Information
7.5.2 Sihuan Pharmaceutical Holdings Group Business Overview
7.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Products Offered
7.5.5 Sihuan Pharmaceutical Holdings Group Recent Development
7.6 Shanghai Soho-Yiming Pharmaceuticals
7.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
7.6.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
7.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Products Offered
7.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Development
7.7 Yibin Pharmaceutical
7.7.1 Yibin Pharmaceutical Company Information
7.7.2 Yibin Pharmaceutical Business Overview
7.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Yibin Pharmaceutical Octreotide Products Offered
7.7.5 Yibin Pharmaceutical Recent Development
8 Octreotide Manufacturing Cost Analysis
8.1 Octreotide Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Octreotide
8.4 Octreotide Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Octreotide Distributors List
9.3 Octreotide Customers
10 Octreotide Market Dynamics
10.1 Octreotide Industry Trends
10.2 Octreotide Market Drivers
10.3 Octreotide Market Challenges
10.4 Octreotide Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Octreotide Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Octreotide Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Octreotide Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Octreotide Sales (Gram) by Region (2020-2025)
Table 5. Global Octreotide Sales Market Share by Region (2020-2025)
Table 6. Global Octreotide Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Octreotide Revenue Share by Region (2020-2025)
Table 8. Global Octreotide Sales (Gram) Forecast by Region (2026-2031)
Table 9. Global Octreotide Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Octreotide Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Octreotide Revenue Share Forecast by Region (2026-2031)
Table 12. Global Octreotide Sales by Type (Gram) & (2020-2025)
Table 13. Global Octreotide Sales Share by Type (2020-2025)
Table 14. Global Octreotide Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Octreotide Price by Type (USD/Gram) & (2020-2025)
Table 16. Global Octreotide Sales by Type (Gram) & (2026-2031)
Table 17. Global Octreotide Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Octreotide Price by Type (USD/Gram) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Octreotide Sales by Application (Gram) & (2020-2025)
Table 21. Global Octreotide Sales Share by Application (2020-2025)
Table 22. Global Octreotide Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Octreotide Price by Application (USD/Gram) & (2020-2025)
Table 24. Global Octreotide Sales by Application (Gram) & (2026-2031)
Table 25. Global Octreotide Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Octreotide Price by Application (USD/Gram) & (2026-2031)
Table 27. New Sources of Growth in Octreotide Application
Table 28. Global Octreotide Sales by Company (Gram) & (2020-2025)
Table 29. Global Octreotide Sales Share by Company (2020-2025)
Table 30. Global Octreotide Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Octreotide Revenue Share by Company (2020-2025)
Table 32. Global Octreotide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Octreotide as of 2024)
Table 33. Global Market Octreotide Average Price by Company (USD/Gram) & (2020-2025)
Table 34. Global Key Manufacturers of Octreotide, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Octreotide, Product Type & Application
Table 36. Global Key Manufacturers of Octreotide, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Octreotide Sales by Company (2020-2025) & (Gram)
Table 39. North America Octreotide Sales Market Share by Company (2020-2025)
Table 40. North America Octreotide Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Octreotide Revenue Market Share by Company (2020-2025)
Table 42. North America Octreotide Sales by Type (2020-2025) & (Gram)
Table 43. North America Octreotide Sales Market Share by Type (2020-2025)
Table 44. North America Octreotide Sales by Application (2020-2025) & (Gram)
Table 45. North America Octreotide Sales Market Share by Application (2020-2025)
Table 46. Europe Octreotide Sales by Company (2020-2025) & (Gram)
Table 47. Europe Octreotide Sales Market Share by Company (2020-2025)
Table 48. Europe Octreotide Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Octreotide Revenue Market Share by Company (2020-2025)
Table 50. Europe Octreotide Sales by Type (2020-2025) & (Gram)
Table 51. Europe Octreotide Sales Market Share by Type (2020-2025)
Table 52. Europe Octreotide Sales by Application (2020-2025) & (Gram)
Table 53. Europe Octreotide Sales Market Share by Application (2020-2025)
Table 54. China Octreotide Sales by Company (2020-2025) & (Gram)
Table 55. China Octreotide Sales Market Share by Company (2020-2025)
Table 56. China Octreotide Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Octreotide Revenue Market Share by Company (2020-2025)
Table 58. China Octreotide Sales by Type (2020-2025) & (Gram)
Table 59. China Octreotide Sales Market Share by Type (2020-2025)
Table 60. China Octreotide Sales by Application (2020-2025) & (Gram)
Table 61. China Octreotide Sales Market Share by Application (2020-2025)
Table 62. Japan Octreotide Sales by Company (2020-2025) & (Gram)
Table 63. Japan Octreotide Sales Market Share by Company (2020-2025)
Table 64. Japan Octreotide Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Octreotide Revenue Market Share by Company (2020-2025)
Table 66. Japan Octreotide Sales by Type (2020-2025) & (Gram)
Table 67. Japan Octreotide Sales Market Share by Type (2020-2025)
Table 68. Japan Octreotide Sales by Application (2020-2025) & (Gram)
Table 69. Japan Octreotide Sales Market Share by Application (2020-2025)
Table 70. India Octreotide Sales by Company (2020-2025) & (Gram)
Table 71. India Octreotide Sales Market Share by Company (2020-2025)
Table 72. India Octreotide Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Octreotide Revenue Market Share by Company (2020-2025)
Table 74. India Octreotide Sales by Type (2020-2025) & (Gram)
Table 75. India Octreotide Sales Market Share by Type (2020-2025)
Table 76. India Octreotide Sales by Application (2020-2025) & (Gram)
Table 77. India Octreotide Sales Market Share by Application (2020-2025)
Table 78. Novartis Company Information
Table 79. Novartis Description and Business Overview
Table 80. Novartis Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 81. Novartis Octreotide Product
Table 82. Novartis Recent Development
Table 83. Sun Pharmaceutical Company Information
Table 84. Sun Pharmaceutical Description and Business Overview
Table 85. Sun Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 86. Sun Pharmaceutical Octreotide Product
Table 87. Sun Pharmaceutical Recent Development
Table 88. Chengdu Tiantaishan pharmaceutical Company Information
Table 89. Chengdu Tiantaishan pharmaceutical Description and Business Overview
Table 90. Chengdu Tiantaishan pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 91. Chengdu Tiantaishan pharmaceutical Octreotide Product
Table 92. Chengdu Tiantaishan pharmaceutical Recent Development
Table 93. Sinopharm A-Think Pharmaceuticals Company Information
Table 94. Sinopharm A-Think Pharmaceuticals Description and Business Overview
Table 95. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 96. Sinopharm A-Think Pharmaceuticals Octreotide Product
Table 97. Sinopharm A-Think Pharmaceuticals Recent Development
Table 98. Sihuan Pharmaceutical Holdings Group Company Information
Table 99. Sihuan Pharmaceutical Holdings Group Description and Business Overview
Table 100. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 101. Sihuan Pharmaceutical Holdings Group Octreotide Product
Table 102. Sihuan Pharmaceutical Holdings Group Recent Development
Table 103. Shanghai Soho-Yiming Pharmaceuticals Company Information
Table 104. Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
Table 105. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 106. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product
Table 107. Shanghai Soho-Yiming Pharmaceuticals Recent Development
Table 108. Yibin Pharmaceutical Company Information
Table 109. Yibin Pharmaceutical Description and Business Overview
Table 110. Yibin Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2020-2025)
Table 111. Yibin Pharmaceutical Octreotide Product
Table 112. Yibin Pharmaceutical Recent Development
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Octreotide Distributors List
Table 116. Octreotide Customers List
Table 117. Octreotide Market Trends
Table 118. Octreotide Market Drivers
Table 119. Octreotide Market Challenges
Table 120. Octreotide Market Restraints
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Octreotide Product Picture
Figure 2. Global Octreotide Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Octreotide Sales Market Share by Type in 2024 & 2031
Figure 4. Octreotide Injection Product Picture
Figure 5. Octreotide Powder Product Picture
Figure 6. Octreotide Microspheres Product Picture
Figure 7. Global Octreotide Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Octreotide Sales Market Share by Application in 2024 & 2031
Figure 9. Treating Severe Diarrhea Examples
Figure 10. Treating Acromegaly Examples
Figure 11. Others Examples
Figure 12. Global Octreotide Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Octreotide Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Octreotide Sales (Gram) Growth Rate (2020-2031)
Figure 15. Global Octreotide Price Trends Growth Rate (2020-2031) & (USD/Gram)
Figure 16. Octreotide Report Years Considered
Figure 17. Global Market Octreotide Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Octreotide Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Octreotide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Octreotide Sales (Gram) Growth Rate (2020-2031)
Figure 21. Europe Octreotide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Octreotide Sales (Gram) Growth Rate (2020-2031)
Figure 23. China Octreotide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Octreotide Sales (Gram) Growth Rate (2020-2031)
Figure 25. Japan Octreotide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Octreotide Sales (Gram) Growth Rate (2020-2031)
Figure 27. India Octreotide Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. India Octreotide Sales (Gram) Growth Rate (2020-2031)
Figure 29. Global Octreotide Revenue Share by Type (2020-2025)
Figure 30. Global Octreotide Sales Share by Type (2026-2031)
Figure 31. Global Octreotide Revenue Share by Type (2026-2031)
Figure 32. Global Octreotide Revenue Share by Application (2020-2025)
Figure 33. Global Octreotide Revenue Growth Rate by Application in 2020 & 2024
Figure 34. Global Octreotide Sales Share by Application (2026-2031)
Figure 35. Global Octreotide Revenue Share by Application (2026-2031)
Figure 36. Global Octreotide Sales Share by Company (2024)
Figure 37. Global Octreotide Revenue Share by Company (2024)
Figure 38. Global 5 Largest Octreotide Players Market Share by Revenue in Octreotide: 2020 & 2024
Figure 39. Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 40. Manufacturing Cost Structure of Octreotide
Figure 41. Manufacturing Process Analysis of Octreotide
Figure 42. Octreotide Industrial Chain
Figure 43. Channels of Distribution (Direct Vs Distribution)
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Octreotide in 2031?
The global market size of Octreotide in 2031 was 2.3 Million USD.
Which region is expected to have the highest market share?
What was the global market size of Octreotide in 2025?
Which companies rank high in the global Octreotide market?
What is the annual compound growth rate of the global Octreotide market size from 2025 to 2031?
Related Reports
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 78
USD 4250.00
(Single User License)
Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 107
USD 3950.00
(Single User License)
Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 132
USD 4900.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 137
USD 5900.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 103
USD 3950.00
(Single User License)
Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published Date: 2025-01-16
Pages: 78
USD 2900.00
(Single User License)
Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-17
Pages: 141
USD 5600.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-16
Pages: 126
USD 5900.00
(Single User License)
Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-07
Pages: 96
USD 4900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 78
USD 4250.00 (Single User License)Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
USD 3950.00 (Single User License)Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 132
USD 4900.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 137
USD 5900.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 103
USD 3950.00 (Single User License)Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published: 2025-01-16
Pages: 78
USD 2900.00 (Single User License)Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-17
Pages: 141
USD 5600.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-16
Pages: 126
USD 5900.00 (Single User License)Global Octreotide Market Insights, Forecast to 2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-07
Pages: 96
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now